Valeo Pharma Inc T.VPH

VPH Big Pharma Capabilities Presents Opportunity

[Sandles]

This one has legs. Good read https://technologymarketwatch.com/vph.htm 

My personal take-aways after reading....

"management, insiders, and directors own ~75% of the company currently, making them perfectly aligned with all other shareholders."

"Valeo Pharma Inc. was essentially rebooted as a new entity in 2015 after its original portfolio was sold to Valeant for C$26 million, representing a 350% return to shareholders, a ROR ROI based on the present value of shareholders investments over a period of years that works out to an after tax return in the high-30% range on an annualized basis."

"Valeo is set to achieve breakeven this 2020, and accelerate revenue-wise from there; revenues are projected to go from ~$10M in 2020 to near $90M within a couple years based on the existing and fast growing product pipeline with the help of two recent product additions"

"Looking at price-to-sales ratio metrics relative to the coming pipeline, shares of VPH are expected to experience solid price appreciation as revenue projections come to fruition, and certainly higher as news develops regarding additions to the pipeline."